ZA989671B - Method of reducing oxalate - Google Patents
Method of reducing oxalateInfo
- Publication number
- ZA989671B ZA989671B ZA989671A ZA989671A ZA989671B ZA 989671 B ZA989671 B ZA 989671B ZA 989671 A ZA989671 A ZA 989671A ZA 989671 A ZA989671 A ZA 989671A ZA 989671 B ZA989671 B ZA 989671B
- Authority
- ZA
- South Africa
- Prior art keywords
- reducing oxalate
- oxalate
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
- C12Y102/03004—Oxalate oxidase (1.2.3.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01002—Oxalate decarboxylase (4.1.1.2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/964,956 US5985938A (en) | 1997-11-05 | 1997-11-05 | Method for reducing oxalate |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA989671B true ZA989671B (en) | 1999-04-28 |
Family
ID=25509224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA989671A ZA989671B (en) | 1997-11-05 | 1998-10-23 | Method of reducing oxalate |
Country Status (10)
Country | Link |
---|---|
US (3) | US5985938A (de) |
EP (2) | EP1645278A3 (de) |
JP (1) | JP4452402B2 (de) |
AR (1) | AR016001A1 (de) |
AU (1) | AU1364799A (de) |
CA (1) | CA2349620C (de) |
DE (1) | DE69833134T2 (de) |
TW (1) | TW585772B (de) |
WO (1) | WO1999022744A1 (de) |
ZA (1) | ZA989671B (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667775A (en) * | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US8486389B2 (en) | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
US5985938A (en) * | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US6566407B2 (en) | 1997-11-05 | 2003-05-20 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
US6733780B1 (en) * | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
US20020054903A1 (en) * | 1999-10-19 | 2002-05-09 | Joseph Tyler | Direct compression polymer tablet core |
GB9927088D0 (en) * | 1999-11-17 | 2000-01-12 | Secr Defence | Use of poly(diallylamine) polymers |
DE10028167B4 (de) * | 2000-06-09 | 2004-02-19 | Storch, Rüdiger, Dr. | Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen |
MXPA03009571A (es) * | 2001-04-18 | 2004-02-12 | Genzyme Corp | Metodo para tratar la gota y unir el acido urico. |
AU2002257147B9 (en) * | 2001-04-18 | 2005-08-18 | Genzyme Corporation | Methods of treating syndrome X with aliphatic polyamines |
WO2002085380A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for treating gout and reducing serum uric acid |
DK1923064T3 (en) * | 2001-04-18 | 2017-10-02 | Genzyme Corp | Use of amine polymer for lowering serum glucose |
EP1923064B1 (de) | 2001-04-18 | 2017-06-28 | Genzyme Corporation | Verwendung von Aminpolymeren zur Minderung des Serumglukosegehaltes |
WO2002085379A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for improving vascular access in patients with vascular shunts |
EP1379258B1 (de) * | 2001-04-18 | 2006-06-28 | Genzyme Corporation | Salzformarme polyallylamine |
CA2442414C (en) | 2001-04-23 | 2011-02-01 | Anormed, Inc. | Use of rare earth compounds for the prevention of kidney stone disease |
US7041280B2 (en) * | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
AU2002363783A1 (en) * | 2001-10-05 | 2003-05-26 | Ixion Biotechnology, Inc. | Materials and methods for reducing oxalate concentrations in fluids |
US6600011B2 (en) * | 2001-10-09 | 2003-07-29 | Genzyme Corporation | Process for purification and drying of polymer hydrogels |
AU2002362735B2 (en) * | 2001-10-09 | 2005-10-13 | Genzyme Corporation | Process for purification and drying of polymer hydrogels |
AU2003282867A1 (en) * | 2002-10-22 | 2004-05-13 | Genzyme Corporation | Amine polymers for promoting bone formation |
US7385012B2 (en) * | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
US7449605B2 (en) * | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
US7767768B2 (en) * | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7335795B2 (en) * | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
PT2269589E (pt) | 2004-03-30 | 2014-02-26 | Relypsa Inc | Polímeros de ligação a ião e seus usos |
EP1755655A4 (de) * | 2004-05-07 | 2011-03-30 | Oxthera Inc | Verfahren und zusammensetzungen zum reduzieren von oxalatkonzentrationen |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
US20060177415A1 (en) * | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
JP2008526771A (ja) * | 2004-12-30 | 2008-07-24 | ジェンザイム コーポレーション | 高リン酸血症のための亜鉛含有処置 |
CA2620406A1 (en) | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
HUE026628T2 (en) | 2005-09-15 | 2016-06-28 | Genzyme Corp | Pouches for amine polymers |
US20090162314A1 (en) * | 2005-11-08 | 2009-06-25 | Huval Chad C | Magnesium-Containing Polymers for the Treatment of Hyperphosphatemia |
PT1962873E (pt) * | 2005-12-14 | 2013-08-29 | Oxthera Inc | Composições farmacêuticas compreendendo bactérias redutoras de oxalato |
CN104013581A (zh) | 2005-12-16 | 2014-09-03 | 奥克斯赛拉公司 | 用于减少草酸和/或其盐的组合物和方法 |
US20080085259A1 (en) * | 2006-05-05 | 2008-04-10 | Huval Chad C | Amine condensation polymers as phosphate sequestrants |
JP2009542653A (ja) * | 2006-07-05 | 2009-12-03 | ジェンザイム コーポレーション | リン酸塩過剰血症のための鉄(ii)含有治療剤 |
EP2043767B1 (de) | 2006-07-14 | 2020-03-25 | Wisconsin Alumni Research Foundation | Adsorptionsmembranen zum einfangen von viren |
CA2658338A1 (en) * | 2006-07-18 | 2008-01-24 | Genzyme Corporation | Amine dendrimers |
RU2009107184A (ru) | 2006-08-02 | 2010-09-10 | Элтус Фармасьютикалз Инк. (Us) | Кристаллизованная оксалатдекарбоксилаза и способы применения |
JP2010504975A (ja) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | アミドデンドリマー組成物 |
US8802094B2 (en) * | 2006-10-25 | 2014-08-12 | Wisconsin Alumni Research Foundation | Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody |
AU2007309026B2 (en) | 2006-10-26 | 2013-09-12 | Aovatechnologies, Inc. | Methods of reducing phosphate absorption |
BRPI0720234A2 (pt) | 2006-12-14 | 2013-12-24 | Genzyme Corp | Composição farmacêutica |
EP2114376A1 (de) * | 2007-02-23 | 2009-11-11 | Genzyme Corporation | Amin-polymerzusammensetzungen |
US20100196305A1 (en) * | 2007-03-08 | 2010-08-05 | Dhal Pradeep K | Sulfone polymer compositions |
WO2008113364A2 (en) * | 2007-03-20 | 2008-09-25 | Recepticon Aps | Amino derivatives to prevent nephrotoxicity and cancer |
EP2152277A1 (de) * | 2007-04-27 | 2010-02-17 | Genzyme Corporation | Amido-amin-dendrimer-zusammensetzungen |
US20100316589A1 (en) * | 2007-12-14 | 2010-12-16 | Hitesh Bhagat | Coated Pharmaceutical Compositions |
FR2928373B1 (fr) | 2008-03-05 | 2010-12-31 | Centre Nat Rech Scient | Polymere derive de la polyethylenimine lineaire pour le transfert de gene. |
US20110142952A1 (en) * | 2008-06-20 | 2011-06-16 | Harris David J | Pharmaceutical Compositions |
WO2010123039A1 (ja) * | 2009-04-21 | 2010-10-28 | 株式会社医学生物学研究所 | 生物学的材料の不動化を行うための組成物 |
WO2014113648A1 (en) | 2013-01-18 | 2014-07-24 | Allena Pharmaceuticals, Inc. | Crystallized oxalate decarboxylase and methods of use |
CA2906501A1 (en) * | 2013-03-15 | 2014-09-25 | Genzyme Corporation | Sequestrants of advanced glycation end product (age) precursors |
JP6574414B2 (ja) | 2013-06-07 | 2019-09-11 | アレナ ファーマシューティカルズ, インコーポレイテッド | 透析のための組成物、方法、および器具 |
US10435528B2 (en) | 2013-09-17 | 2019-10-08 | Aquanano Llc | High-capacity anion exchange materials |
MA41202A (fr) | 2014-12-18 | 2017-10-24 | Genzyme Corp | Copolymères polydiallymine réticulé pour le traitement du diabète de type 2 |
US11603524B2 (en) | 2015-04-02 | 2023-03-14 | Oxidien Pharmaceuticals, Llc | High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate |
GB201718803D0 (en) * | 2017-11-14 | 2017-12-27 | Phoenix Molecular Pte Ltd | Method for isolation of nucleic acids |
WO2019236858A1 (en) * | 2018-06-06 | 2019-12-12 | The Board Of Trustees Of The University Of Illinois | Zwitterionic biocompatible polymers, methods, and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198396A (en) * | 1974-07-03 | 1980-04-15 | Warren-Teed Laboratories, Inc. | Dissolution of gallstones |
US4143130A (en) * | 1977-08-29 | 1979-03-06 | Warren-Teed Laboratories, Inc. | Method for treating kidney stones |
JPS60202869A (ja) * | 1984-03-26 | 1985-10-14 | Ajinomoto Co Inc | 大環状ポリアミン誘導体及びその用途 |
DE3727082A1 (de) * | 1987-08-14 | 1989-02-23 | Goedecke Ag | Pharmazeutische zubereitungen zur behandlung der urolithiasis |
US5244913A (en) * | 1991-11-19 | 1993-09-14 | Baxter International Inc. | Compositions and methods for dissolving body calculi |
US5487888A (en) * | 1993-05-20 | 1996-01-30 | Geltex, Inc. | Iron-binding polymers for oral administration |
US5618530A (en) * | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
US5703188A (en) * | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5624963A (en) * | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5607669A (en) * | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
US5667775A (en) * | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5496545A (en) * | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
TW474813B (en) * | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
TR199901613T2 (xx) * | 1996-10-23 | 1999-10-21 | The Dow Chemical Company | Diyet ile al�nan fosfat veya oksalat emilimini azaltmaya ili�kin suda ��z�nen polimerler |
US5985938A (en) * | 1997-11-05 | 1999-11-16 | Geltex Pharmaceuticals, Inc. | Method for reducing oxalate |
-
1997
- 1997-11-05 US US08/964,956 patent/US5985938A/en not_active Expired - Lifetime
-
1998
- 1998-10-23 ZA ZA989671A patent/ZA989671B/xx unknown
- 1998-10-26 AU AU13647/99A patent/AU1364799A/en not_active Abandoned
- 1998-10-26 EP EP05076677A patent/EP1645278A3/de not_active Withdrawn
- 1998-10-26 DE DE69833134T patent/DE69833134T2/de not_active Expired - Lifetime
- 1998-10-26 JP JP2000518676A patent/JP4452402B2/ja not_active Expired - Lifetime
- 1998-10-26 CA CA002349620A patent/CA2349620C/en not_active Expired - Fee Related
- 1998-10-26 EP EP98957371A patent/EP1044008B1/de not_active Expired - Lifetime
- 1998-10-26 WO PCT/US1998/022606 patent/WO1999022744A1/en active IP Right Grant
- 1998-11-03 TW TW087118238A patent/TW585772B/zh not_active IP Right Cessation
- 1998-11-03 AR ARP980105513A patent/AR016001A1/es unknown
-
1999
- 1999-07-22 US US09/359,226 patent/US6177478B1/en not_active Expired - Lifetime
-
2000
- 2000-09-25 US US09/668,874 patent/US6281252B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU1364799A (en) | 1999-05-24 |
US5985938A (en) | 1999-11-16 |
AR016001A1 (es) | 2001-05-30 |
EP1645278A3 (de) | 2007-11-14 |
JP4452402B2 (ja) | 2010-04-21 |
WO1999022744A1 (en) | 1999-05-14 |
EP1645278A2 (de) | 2006-04-12 |
DE69833134D1 (de) | 2006-03-30 |
EP1044008B1 (de) | 2006-01-04 |
CA2349620C (en) | 2008-04-08 |
TW585772B (en) | 2004-05-01 |
EP1044008A1 (de) | 2000-10-18 |
US6281252B1 (en) | 2001-08-28 |
JP2001521902A (ja) | 2001-11-13 |
CA2349620A1 (en) | 1999-05-14 |
DE69833134T2 (de) | 2006-08-10 |
US6177478B1 (en) | 2001-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA989671B (en) | Method of reducing oxalate | |
GB2345063B (en) | Method | |
GB9706282D0 (en) | Method | |
PL334701A1 (en) | Novel method | |
GB9700320D0 (en) | Method | |
PL335163A1 (en) | Method of obtaining substituted thiazolydinodione | |
PL335074A1 (en) | Method of obtaining eprosartane | |
EP0997450A4 (de) | VERFAHREN ZUM REDUZIEREN VON NO x | |
PL335075A1 (en) | Method of obtaining eprosartane | |
ZA9810471B (en) | New method | |
GB9707744D0 (en) | Method | |
PL334901A1 (en) | Method of obtaining benzothiazolones | |
GB2325438B (en) | Method of printing | |
PL339188A1 (en) | Method of obtaining oxaphosphorin-2-amines | |
PL341358A1 (en) | Method of obtaining paroxetin chlorhydride | |
PL340915A1 (en) | Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides | |
GB9704499D0 (en) | Method of manufacture | |
GB9720059D0 (en) | Method of bonding | |
PL341302A1 (en) | Method of obtaining chlorobenzoxazoles | |
PL336266A1 (en) | Method of obtaining epsilon-caprolactams | |
GB9707251D0 (en) | Novel method and compounds | |
PL340497A1 (en) | Method of obtaining formylimidazoles | |
GB9725462D0 (en) | Novel method | |
GB9709811D0 (en) | Method | |
PL338015A1 (en) | Method of obtaining cithaloprame |